Oral semaglutide demonstrated superior cardiometabolic outcomes relative to placebo and active comparators, including empaglifozin, in T2D.

Experts say 85% price drop in empagliflozin expected to boost SGLT2 usage; SGLT-2 class of drugs account for 25-30% of all diabetes prescriptions ...

Researchers sourced data from the EASE-2 and -3 clinical trials to assess the effect of SGLT2i use on cardiovascular disease risk among patients with type 1 diabetes.

Abstracts featured at the National Kidney Foundation Spring Clinical Meeting highlighted the renoprotective benefits of SGLT2 ...

New Delhi: Through a recent notice, the National Pharmaceutical Pricing Authority (NPPA), Ministry of Chemicals and ...

The country’s pharmaceuticals market grew by 8.4 per cent during financial year 2024-25 on the back of major therapies showing positive value growth, according to market research firm Pharmarack.

SGLT2 inhibitors are medications designed to help manage blood sugar in people living with type 2 diabetes. Learn more about the different types, as well as the benefits and side effects. Sodium ...

Clinical question: Is there an association between baseline dietary sodium intake and clinical outcomes in heart failure? Background: Dietary sodium restriction is common advice for patients with ...

At the American College of Cardiology’s 74th Annual Scientific Session in Chicago, further results and analyses were presented from the SUMMIT trial. SUMMIT was the first trial in patients with heart ...

Ajaduo M Forte combines three well-established agents- Empagliflozin, Linagliptin, and Metformin Extended Release (ER)- into a single daily tablet, simplifying treatment regimens for patients ...

Almost 38 out of the total formulations for which the prices fixed in the meeting were of various formulations and strengths comprising empagliflozin, the anti-diabetes drug for which Boehringer ...